Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Boehringer Ingelheim
Baxter
Federal Trade Commission
Argus Health
Farmers Insurance

Generated: August 25, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,358,352

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,358,352
Title:Dry powder drug delivery system and methods
Abstract: A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, small organic molecules, peptides and proteins, including, insulin and glucagon-like peptide 1 for the treatment of disease and disorders, for example, endocrine disease such as diabetes and/or obesity.
Inventor(s): Smutney; Chad C. (Watertown, CT), Adamo; Benoit (Mount Kisco, NY), Polidoro; John M. (Coventry, CT), Kinsey; P. Spencer (Sandy Hook, CT), Overfield; Dennis (Fairfield, CT), Sahi; Carl (Coventry, CT), Billings; Christine (Danbury, CT), Marino; Mark T. (Danbury, CT)
Assignee: MannKind Corporation (Valencia, CA)
Application Number:13/702,024
Patent Claim Types:
see list of patent claims
Delivery; Formulation; Compound; Use;

Drugs Protected by US Patent 9,358,352

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mannkind AFREZZA insulin recombinant human POWDER;INHALATION 022472-001 Jun 27, 2014 RX Yes No   Try a Free Trial   Try a Free Trial Y USE OF AN INHALER TO ADMINISTER DRY POWDER MEDICAMENT   Try a Free Trial
Mannkind AFREZZA insulin recombinant human POWDER;INHALATION 022472-002 Jun 27, 2014 RX Yes Yes   Try a Free Trial   Try a Free Trial Y USE OF AN INHALER TO ADMINISTER DRY POWDER MEDICAMENT   Try a Free Trial
Mannkind AFREZZA insulin recombinant human POWDER;INHALATION 022472-003 Apr 17, 2015 RX Yes No   Try a Free Trial   Try a Free Trial Y USE OF AN INHALER TO ADMINISTER DRY POWDER MEDICAMENT   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,358,352

PCT Information
PCT FiledJune 21, 2011PCT Application Number:PCT/US2011/041303
PCT Publication Date:December 29, 2011PCT Publication Number: WO2011/163272

International Family Members for US Patent 9,358,352

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 072114   Try a Free Trial
Argentina 104034   Try a Free Trial
Argentina 104035   Try a Free Trial
Australia 2003257156   Try a Free Trial
Australia 2006290227   Try a Free Trial
Australia 2006290870   Try a Free Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Julphar
Colorcon
Cipla
Chubb
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.